Nerve News and Research

RSS

Thickness of the cornea an important factor in considering treatment options for patients with glaucoma

Thickness of the cornea, the thin, transparent layer covering the eye, may be an important factor in considering treatment options for patients with glaucoma, according to an article appearing in the September issue of The Archives of Ophthalmology, one of the JAMA/Archives journals.

12 Sep 2004

Chiropractic correction may help reverse multiple sclerosis and Parkinson’s disease

A recent study of 81 cases, published in the Journal of Vertebral Subluxation Research (JVSR), is the first to show that correction of upper neck injuries may reverse the progression of both Multiple Sclerosis (MS) and Parkinson’s disease (PD).

10 Sep 2004

New device aimed at detecting glaucoma

The physician who revolutionized screening methods for glaucoma nearly 20 years ago has patented a new device aimed at detecting glaucoma, a leading cause of blindness.

10 Sep 2004

Discovery of way to regulate brain blood could lead to new treatments for stroke, migraine, Alzheimer’s

There may be new treatments for stroke, migraine, Alzheimer’s and other brain disorders, thanks to the discovery of a mechanism for regulating brain blood flow made by researchers at the University of British Columbia.

10 Sep 2004

Disruption of protein folding causes neurodegeneration, mental retardation

Excess accumulation in brain cells of a fat molecule called GM1-ganglioside (GM1) disrupts the folding of newly assembled proteins into their proper shapes, triggering nerve degeneration and mental retardation in children.

10 Sep 2004

Chemical pathways of serotonin in the nervous system pave way for future pharmaceutical treatments for depression

From mollusks to mammals, newly discovered chemical pathways of serotonin in the nervous system are paving a path toward future pharmaceutical treatments for depression and other disorders.

10 Sep 2004

Findings about diabetic eye disease may lead to improved screenings and treatment for people with diabetes

Eli Lilly and Company have announced key findings from analyses of prior study data that enhances understanding of vision loss due to diabetic retinopathy, a diabetic microvascular complication that affects an estimated 50 million people worldwide.

10 Sep 2004

Scientists closer to correcting an abnormal gene which causes Charcot-Marie-Tooth disease

Scientists at the University of Edinburgh are closer to correcting an abnormal gene which causes one of the crippling muscle wasting diseases known collectively as Charcot-Marie-Tooth (CMT) disease.

10 Sep 2004

New research into stimulus-related ear differences from birth may provide improved methods for newborn hearing tests

Researchers have known since the 1950s that humans process speech and tone sounds in different sides of the brain.

10 Sep 2004

Exubera shows sustained blood glucose control in patients with type 2 diabetes

New data showed that Exubera (inhaled insulin) was effective and well tolerated in controlling blood glucose levels over a two-year period in patients with Type 2 diabetes.

8 Sep 2004

First indication that Parkinson’s disease can be caused by a defect in a protein

The findings of Finnish scientists with their multinational collaborators shed light to the mechanisms of Parkinson’s disease and early menopause.

8 Sep 2004

First step in using gene therapy to treat glaucoma

Mayo Clinic researchers have demonstrated they can permanently transfer a functioning gene to targeted tissues within the eye.

2 Sep 2004

Omega-3 supplement may help protect against Alzheimer's

Higher intake of fatty, cold-water fish (such as tuna, salmon, and mackerel) has long been associated with a lower risk of dementia and Alzheimer's and epidemiological studies suggest that dietary supplements of omega-3 polyunsaturated fatty acids might also protect against Alzheimer's disease.

1 Sep 2004

Ultra-sensitive measurement technique shows how biomolecular motors carry out essential tasks

In the human body, hundreds of different types of biomolecular motors help carry out such essential tasks as muscle contraction, moving chromosomes during cell division, and reloading nerve cells so they can repeatedly fire.

30 Aug 2004

Cymbalta, treatment for major depression hits the market

Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company has announced.

26 Aug 2004

Cymbalta, a new treatment for major depression

Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company have announced.

25 Aug 2004

Gray matter in brain associated with language processing among people with a family history of dyslexia

Italian researchers have observed significant reductions of gray matter volume in areas of the brain associated with language processing among people with a family history of dyslexia in comparison with controls with no reading problems.

24 Aug 2004

Effectiveness of gingko to treat early dementia

Researchers in London are to explore the effectiveness of gingko, a complementary medicine traditionally used to treat circulatory problems, as a treatment for early dementia.

23 Aug 2004

Evidence of pelvic floor nerve injury after routine vaginal birth

Women with pelvic floor disorders suffer from urinary and fecal incontinence as well as prolapse of the bowel, bladder and reproductive organs. (Bowel prolapse occurs when the bowel slips out of place, and pushes up against the walls of the vagina, which may cause a great deal of discomfort.)

20 Aug 2004

Sea snail offers natural healing powers for a range of illnesses from chronic pain to diseases of the brain

A beautiful, but often deadly, snail from the sea has been revealed as a largely untapped source of natural healing powers for a range of illnesses from chronic pain to diseases of the brain.

20 Aug 2004

Nerve News and Research

Thickness of the cornea an important factor in considering treatment options for patients with glaucoma

Chiropractic correction may help reverse multiple sclerosis and Parkinson’s disease

New device aimed at detecting glaucoma

Discovery of way to regulate brain blood could lead to new treatments for stroke, migraine, Alzheimer’s

Disruption of protein folding causes neurodegeneration, mental retardation

Chemical pathways of serotonin in the nervous system pave way for future pharmaceutical treatments for depression

Findings about diabetic eye disease may lead to improved screenings and treatment for people with diabetes

Scientists closer to correcting an abnormal gene which causes Charcot-Marie-Tooth disease

New research into stimulus-related ear differences from birth may provide improved methods for newborn hearing tests

Exubera shows sustained blood glucose control in patients with type 2 diabetes

First indication that Parkinson’s disease can be caused by a defect in a protein

First step in using gene therapy to treat glaucoma

Omega-3 supplement may help protect against Alzheimer's

Ultra-sensitive measurement technique shows how biomolecular motors carry out essential tasks

Cymbalta, treatment for major depression hits the market

Cymbalta, a new treatment for major depression

Gray matter in brain associated with language processing among people with a family history of dyslexia

Effectiveness of gingko to treat early dementia

Evidence of pelvic floor nerve injury after routine vaginal birth

Sea snail offers natural healing powers for a range of illnesses from chronic pain to diseases of the brain

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News